Introduction {#sec1}
============

Long non-coding RNAs (lncRNAs) with lengths of more than 200 nucleotides are known to play important roles in contributing to a large variety of diseases, such as cancer and cardiovascular diseases ([@ref1]), and are used as biomarkers in cancer diagnoses ([@ref4]). As the researches focusing on the relationship between lncRNA and disease accumulated over the past decade, it became necessary to integrate the reported-associations to get a systematic overview of the lncRNA-disease relationships. For this purpose, we launched our first release of the lncRNA disease database (LncRNADisease) ([@ref5]) in 2012 and developed the LncRNADisease 2 ([@ref6]) in 2018 with a 40-fold expansion in volume and the integration of associations between circular RNAs (circRNAs) and diseases.

Among all kinds of lncRNA--disease associations, the causal ones have received the most attentions, because they can provide the strongest evidence related to pathogenesis ([@ref7]). Hence, screening the causal associations is of great importance, and such causality information should be included in the database. However, current LncRNADisease and other similar databases ([@ref8],[@ref9]) do not provide such information. Given this, we updated the LncRNADisease by integrating the causality information of the lncRNA--disease associations. To our knowledge, it is the first lncRNA--disease association database that provides causality information. The updated information and functions may shed substantial light on future studies in this area.

![The workflow in annotating the causality information for lncRNA-- and circRNA--disease associations.](baz150f1){#f1}

Results {#sec2}
=======

This update mainly focused on providing the causality information of lncRNA-- and circRNA--disease associations. We defined disease causative lncRNAs and circRNAs as those that could directly contribute to the development or progress of a disease. The workflow is shown in [Figure **1**](#f1){ref-type="fig"}. Of the total 11 568 experimental associations, around one fifth of both lncRNA-- and circRNA--disease associations were identified to be causal, including 2297 out of 10 564 for lncRNAs and 198 out of 1004 for circRNAs ([Figure **2**A and B](#f2){ref-type="fig"}). In total, 635 lncRNAs and 126 circRNAs were identified to be causative for at least one disease. NcRNAs (lncRNAs and circRNAs) with the greatest number of causal diseases are listed in [Table **1**](#TB1){ref-type="table"}. Diseases with the greatest number of causative ncRNAs are all cancers ([Table **2**](#TB2){ref-type="table"}), which may be due to the complex nosogenesis of cancers. Distribution plots show that most causative ncRNAs have less than two causal diseases, and most causal diseases have less than five causative ncRNAs ([Figure **2**C and D](#f2){ref-type="fig"}). The number of causality related publications and the fraction of these publications have been significantly increasing since 2013 ([Figure **2**E and F](#f2){ref-type="fig"}).

![A statistical profile of the causality information of the new update of lncRNADisease. Pie charts show the distribution of causal lncRNA--disease (**A**) and circRNA--disease (**B**) associations. In total, 2297 out of 10 564 lncRNA--disease associations and 198 out of 1004 circRNA--disease associations were identified to be causal. Distribution plots show the number of causal diseases for causative ncRNAs (**C**) and the number of causative ncRNAs for causal diseases (**D**). Bar plots show the number of causality related publications (**E**) and the fraction of causality related publications (**F**).](baz150f2){#f2}

###### 

LncRNAs and circRNAs with the greatest number of causal diseases

  lncRNA category   lncRNA symbol      Number of causal diseases
  ----------------- ------------------ ---------------------------
  lncRNA            MALAT1             62
                    HOTAIR             50
                    H19                45
                    MEG3               37
                    TUG1               30
                    GAS5               29
                    PVT1               28
                    UCA1               26
                    NEAT1              25
                    CDKN2B-AS1         22
                    CCAT1              22
  circRNA           hsa_circ_0000284   9
                    CDR1-AS            7
                    circ-Foxo3         5
                    hsa_circ_0001313   4

###### 

Diseases with the greatest number of causative ncRNAs

  Disease name                     Number of causative ncRNAs
  -------------------------------- ----------------------------
  Hepatocellular carcinoma         121
  Stomach cancer                   113
  Colorectal cancer                108
  Non--small-cell lung carcinoma   88
  Breast cancer                    82
  Osteosarcoma                     55
  Lung cancer                      53
  Prostate cancer                  44
  Glioma                           43

In addition, to provide some implications in molecular mechanism, we categorized the causal associations into several dysfunction patterns (annotated in the last version), including expression, regulation and interaction patterns, which represent different levels in regulation of gene expression when contributing to the development or progress of a disease ([Table **3**](#TB3){ref-type="table"}). Causal associations have more disagreements than other (annotated as not causal) associations in regulation patterns, for 7.08% (76 out of 1073) causal associations have references for both up- and downregulations, and 1.64% (98 out of 5974) for other associations. This result may be due to the research bias for the causative ncRNAs.

Moreover, we compared causative human lncRNAs with non-causative ones in the database with 109 features using an online tool LnCompare ([@ref10]), and the significant results are shown in [Figure **3**](#f3){ref-type="fig"}. The causative lncRNAs have higher expression level in different cell types, higher GC content, shorter distance to the closest protein coding gene and shorter gene and exon length.

Materials and methods {#sec3}
=====================

Data collection {#sec4}
---------------

We downloaded the MySQL database from the latest version of LncRNADisease to ensure all data was collected in the original database. Experimental associations with references (11 568 in total) were extracted from the corresponding table of the database.

###### 

Statistical summary for the dysfunction patterns of the causal associations

  Dysfunction pattern                      Causal association counting
  ---------------------------------------- -----------------------------
  Expression \[high/over expression\]      311
  Expression \[low expression\]            61
  Regulation \[upregulated\]               984
  Regulation \[downregulated\]             309
  Interaction/regulation \[microRNA\]      525
  Interaction/regulation \[protein\]       206
  Interaction/regulation \[mRNA/lncRNA\]   5

The dysfunction patterns were extracted and counted from the annotations in the database.

![The comparisons between causative and other human lncRNAs. Wilcoxon rank-sum tests were performed on the webserver of LnCompare for comparison analyses of 124 causative human lncRNAs and 509 other (manually annotated as non-causative) human lncRNAs using 109 features. The analysis only performed on lncRNAs with Ensembl IDs. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, error bars show the SEM.](baz150f3){#f3}

Annotation for the causal associations {#sec5}
--------------------------------------

We manually annotated the causal associations by reviewing the abstracts of related publications. Causal associations were identified by the corresponding following criteria: (i) Functional experiments like gain-of-function and/or loss-of-function experiments must be performed on the exact lncRNAs or circRNAs and (ii) functional experiments must be conducted on cell lines and/or animal models of human diseases. Associations were excluded if the research only acknowledged the relationships between lncRNA or circRNA and drug effects but not the disease per se. To ensure the accuracy of the curation, the annotated causality information had been crosschecked by different researchers. In total, 2531 associations were annotated to be causal at first, whereas 70 were removed and another 34 were added after crosscheck. As the criteria were quite clear, the disagreements in annotation were mainly due to wrong judgments led by manual work.

Implementation {#sec6}
--------------

We updated the MySQL database of LncRNADisease 2.0 on the website with causality information. The web interface for browsing and searching was implemented by PHP and JavaScript programs. Apache Tomcat web server was used for the http server.

Database usage {#sec7}
--------------

Users can browse all the lncRNA-- and circRNA--disease causal associations using the 'Causality' filter on the BROWSE page, with 'Yes' option means at least one reference in the associations is annotated to be causal, 'Unknown' option means no references in the associations are annotated to be causal, and 'Not Available' option for predicted associations or experimental associations with references no longer available in the PubMed.

In addition, two new sections 'ncRNA Association Statistics' and 'Disease Association Statistics' are available in the Entry Detail page (users can enter the Entry Detail page from Search Results page or BROWSE page). In these two sections, total associated disease/non-coding RNA (ncRNA) number, causal disease/ncRNA number, a network of each ncRNA/disease and its associated diseases/ncRNAs are shown. More information for each associated disease/ncRNA, such as species, IDs, definitions and its causality information, are also provided for users to browse and download for further analysis. The causality information (Yes/No) is also added in each reference of an association on the Entry Detail page. 'Yes' or 'No' means that in which reference this association is annotated to be causal or not causal.

Users can also download all the causal associations on the DOWNLOAD page. The STATISTICS, SUBMIT and HELP pages were updated as well, with changes related to causality information.

Perspectives and concluding remarks {#sec8}
-----------------------------------

Disease causative lncRNAs and circRNAs directly contribute to the development or progress of a disease relative to others that are passively altered during a disease process. The identification of the disease causative ncRNAs is of great importance for understanding how they contribute to diseases ([@ref7],[@ref11]). The causality information we updated provides a valuable source for future researches, such as defining the research potential of the disease-related ncRNAs, screening the ncRNA drug targets or predicting the causal ncRNA-disease associations.

With the identified causative lncRNAs and circRNAs, some function implications can offer help to see whether causative and other ncRNAs function differently in a disease. However, currently, there is no tool that can directly perform the functional enrichment analysis for lncRNAs/circRNAs. Therefore, we only provide basic information for all associated lncRNAs and circRNAs for a given disease in this version. We may introduce the function enrichment result to the database when lncRNA enrichment analysis tools are available.
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